Glycyrrhizic Acid
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB13751 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 100 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | multiple endocrine neoplasia | KG + DL |
| 2 | amenorrhea (disease) | KG + DL |
| 3 | hypoalphalipoproteinemia | KG + DL |
| 4 | infectious bovine rhinotracheitis | KG + DL |
| 5 | malignant catarrh | KG + DL |
| 6 | cytomegalovirus infection | KG + DL |
| 7 | acne (disease) | KG + DL |
| 8 | kyphoscoliotic heart disease | KG + DL |
| 9 | pulmonary hypertension | KG + DL |
| 10 | rheumatoid arthritis | KG + DL |
| 11 | hyperthyroidism | KG + DL |
| 12 | benign recurrent intrahepatic cholestasis | KG + DL |
| 13 | drug-induced osteoporosis | KG + DL |
| 14 | resistance to thyroid hormone due to a mutation in thyroid hormone receptor beta | KG + DL |
| 15 | colobomatous microphthalmia-rhizomelic dysplasia syndrome | KG + DL |
| 16 | brachydactyly-syndactyly syndrome | KG + DL |
| 17 | blindness (disorder) | KG + DL |
| 18 | gout | KG + DL |
| 19 | seborrheic dermatitis | KG + DL |
| 20 | adrenal gland hyperfunction | KG + DL |
| 21 | postmenopausal osteoporosis | KG + DL |
| 22 | cholestasis | KG + DL |
| 23 | pregnancy associated osteoporosis | KG + DL |
| 24 | breast fibrocystic disease | KG + DL |
| 25 | primary hereditary glaucoma | KG + DL |
| 26 | familial intrahepatic cholestasis | KG + DL |
| 27 | primary release disorder of platelets | KG + DL |
| 28 | psoriasis | KG + DL |
| 29 | hereditary North American Indian childhood cirrhosis | KG + DL |
| 30 | benign mammary dysplasia | KG + DL |
| 31 | Graves disease | KG + DL |
| 32 | microvillus inclusion disease | KG + DL |
| 33 | inborn disorder of bilirubin metabolism | KG + DL |
| 34 | open-angle glaucoma | KG + DL |
| 35 | homozygous familial hypercholesterolemia | KG + DL |
| 36 | Worth syndrome | KG + DL |
| 37 | autosomal dominant neovascular inflammatory vitreoretinopathy | KG + DL |
| 38 | duodenal obstruction | KG + DL |
| 39 | bilirubin metabolism disease | KG + DL |
| 40 | non-syndromic visceral malformation | KG + DL |
| 41 | peripheral vascular disease | KG + DL |
| 42 | zinc, elevated plasma | KG + DL |
| 43 | duodenal ulcer (disease) | KG + DL |
| 44 | biliary atresia intrahepatic | KG + DL |
| 45 | roseolovirus infectious disease | KG + DL |
| 46 | duodenogastric reflux | KG + DL |
| 47 | nevus of Ito | KG + DL |
| 48 | mitochondrial DNA depletion syndrome, hepatocerebral form | KG + DL |
| 49 | pseudo-von Willebrand disease | KG + DL |
| 50 | bone Paget disease | KG + DL |
(Showing top 50 of 100 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.